The final, formatted version of the article will be published soon.
BRIEF RESEARCH REPORT article
Front. Med.
Sec. Hepatobiliary Diseases
Volume 11 - 2024 |
doi: 10.3389/fmed.2024.1475997
This article is part of the Research Topic Treatment and Prognostic Assessment of Liver Cirrhosis and Its Complications, Volume II View all 18 articles
Spleen stiffness measurements during recompensation in patients with acutely decompensated liver cirrhosis: preliminary findings of a pilot study
Provisionally accepted- University Hospital of Cologne, Cologne, Germany
Acute decompensation (AD) in patients with liver cirrhosis is associated with a dramatic deterioration in prognosis. Immediate initiation of appropriate recompensation measures is essential to improve patient's outcome, although objective parameters for evaluating the success of recompensation are still lacking. Spleen stiffness measurements (SSM) have emerged as promising non-invasive tool to assess clinically significant portal hypertension (CSPH), which is the main driver of acute decompensation. However, while SSM accurately predicts CSPH and its complication, currently no data are available on its diagnostic performance during recompensation. This pilot-study aimed at evaluating changes in spleen stiffness following the initiation of recompensation measures in cirrhotic patients hospitalized due to AD.In this prospective pilot-study, 60 patients with cirrhosis showing AD were included liver stiffness measurements (LSM) and SSM on admission day with repetitive SSM on day 3 and 5, respectively, during recompensation measures. A cohort of patients (n=10) with compensated cirrhosis served as control.Results: 36 data sets from the originally enrolled 60 patients were eligible for final analysis. On admission, patients with AD revealed a significantly increased spleen stiffness compared to the control group (70.51 vs. 29.06 kPa, p<0.0001). Following the initiation of recompensation measures SSM revealed a significant reduction in spleen stiffness compared to the baseline assessment on day 3 (-18.5 kPa, -21.53%; p=0.0002) with no further decrease on day 5 (-17.63 kPa, -21.23%; p=0.0326).Repetitive SSM seems to be a useful non-invasive clinical marker to assess the effectiveness of recompensation measures in cirrhotic patients with AD.
Keywords: Spleen stiffness, SSM, portal hypertension, Decompensation, Decompensated cirrhosis, CSPH, Recompensation
Received: 04 Aug 2024; Accepted: 28 Oct 2024.
Copyright: © 2024 Gülcicegi, Hannemann, Buerger, Allo, Dittmann, Martin, Jaspers, Holzapfel, Seung-Hun, Lang, Goeser, Steffen and Kasper. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Dilan Elcin Gülcicegi, University Hospital of Cologne, Cologne, Germany
Philipp Kasper, University Hospital of Cologne, Cologne, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.